mDCF + Avelumab in Resectable Esophago-gastric Adenocarcinoma (EGA)

Clinical trial NCT03288350 · UNKNOWN

Trial details

NCT number: NCT03288350
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Gastric Adenocarcinoma Esophageal Adenocarcinoma

Start date: 2018-02-22
Primary completion: 2020-12-01
Enrollment: 55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.